Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer
Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page
- Check3 days agoChange DetectedThe page’s revision/version label was updated from v3.5.2 to v3.5.3, reflecting a site software release rather than a change to the underlying study details.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed from the revision log.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe term 'Small cell lung carcinoma' was added to the list of tumor types. This aligns terminology but does not alter any study details or requirements.SummaryDifference0.0%

- Check39 days agoChange DetectedHepatocellular carcinoma was added to the list of study conditions. The page revision was updated to version 3.5.0.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check75 days agoChange DetectedThe changes include a minor site revision to v3.4.2 and the removal of the government funding status notice (and Revision: v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer
Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.